Transcribed

Personal journeys and hard-earned lessons behind biotech’s biggest breakthroughs

Featured interview

with Eric Kelsic

CEO and co-founder
Dyno Therapeutics

What if we could redesign biology itself to create molecules with outsized impact on human health? Dyno CEO Eric Kelsic shares how ML-designed AAV capsids are tackling the biggest challenge in gene therapy — in vivo delivery.

View now

Podcast available on

More stories

Listen

Andrew Bellinger on contrarian bets — and pioneering gene editing at Verve

Watch

Jake Becraft on going all in on mRNA and proving skeptics wrong

Watch

Karen Akinsanya on the future of computational drug discovery and Schrödinger’s model for success

Read

John Tsai on the power of clinical development and the road to blockbuster drugs

Watch

Sara Kenkare-Mitra on saving drug programs and following your curiosity

Watch

Patrick Hsu on betting big: CRISPR, AI, and building science in the open

Transcribed